Jack A. Khattar is President, CEO of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 926,172 shares of SUPN, which is worth approximately $33.5 Million. The most recent transaction as insider was on Nov 08, 2024, when has been sold 125,000 shares (Common Stock) at a price of $36.29 per share, resulting in proceeds of $4,536,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 926K
1.2% 3M change
6.77% 12M change
Total Value Held $33.5 Million

Jack A. Khattar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2024
SELL
Open market or private sale
$4,536,250 $36.29 p/Share
125,000 Reduced 11.89%
926,172 Common Stock
Nov 08 2024
BUY
Exercise of conversion of derivative security
$1,141,250 $9.13 p/Share
125,000 Added 10.63%
1,051,172 Common Stock
Nov 07 2024
SELL
Open market or private sale
$4,585,000 $36.68 p/Share
125,000 Reduced 11.89%
926,172 Common Stock
Nov 07 2024
BUY
Exercise of conversion of derivative security
$1,141,250 $9.13 p/Share
125,000 Added 10.63%
1,051,172 Common Stock
Sep 03 2024
SELL
Payment of exercise price or tax liability
$350,570 $34.9 p/Share
10,045 Reduced 1.07%
926,172 Common Stock
Sep 03 2024
BUY
Exercise of conversion of derivative security
-
21,000 Added 2.19%
936,217 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$469,056 $27.94 p/Share
16,788 Reduced 1.8%
915,217 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
35,000 Added 3.62%
932,005 Common Stock
Feb 12 2024
BUY
Other acquisition or disposition
-
16,500 Added 1.81%
897,005 Common Stock
Dec 22 2023
SELL
Payment of exercise price or tax liability
$330,758 $27.66 p/Share
11,958 Reduced 1.34%
880,505 Common Stock
Dec 22 2023
BUY
Exercise of conversion of derivative security
-
25,000 Added 2.72%
892,463 Common Stock
Sep 07 2023
SELL
Payment of exercise price or tax liability
$539,408 $32.1 p/Share
16,804 Reduced 1.9%
867,463 Common Stock
Sep 07 2023
BUY
Exercise of conversion of derivative security
-
35,000 Added 3.81%
884,267 Common Stock
May 11 2023
SELL
Payment of exercise price or tax liability
$547,232 $36.47 p/Share
15,005 Reduced 1.74%
849,267 Common Stock
May 11 2023
BUY
Exercise of conversion of derivative security
-
31,250 Added 3.49%
864,272 Common Stock
Mar 14 2023
BUY
Exercise of conversion of derivative security
-
20,000 Added 2.34%
833,022 Common Stock
Feb 15 2023
BUY
Other acquisition or disposition
-
8,750 Added 1.06%
813,022 Common Stock
Feb 03 2023
BUY
Open market or private sale
$8,404 $42.02 p/Share
200 Added 0.02%
804,272 Common Stock
Feb 03 2023
BUY
Exercise of conversion of derivative security
$3,154 $9.56 p/Share
330 Added 0.04%
804,472 Common Stock
Feb 02 2023
SELL
Open market or private sale
$569,020 $42.05 p/Share
13,532 Reduced 1.65%
804,142 Common Stock
Feb 02 2023
BUY
Exercise of conversion of derivative security
$215,243 $9.56 p/Share
22,515 Added 2.68%
817,674 Common Stock
Feb 01 2023
SELL
Open market or private sale
$12,603 $42.01 p/Share
300 Reduced 0.04%
795,159 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
$4,760 $9.56 p/Share
498 Added 0.06%
795,459 Common Stock
Jan 31 2023
SELL
Open market or private sale
$41,001 $42.01 p/Share
976 Reduced 0.12%
794,961 Common Stock
Jan 31 2023
BUY
Exercise of conversion of derivative security
$15,487 $9.56 p/Share
1,620 Added 0.2%
795,937 Common Stock

Also insider at

SCPH
scPharmaceuticals Inc. Healthcare
CGTX
COGNITION THERAPEUTICS INC Healthcare
JAK

Jack A. Khattar

President, CEO
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN